1-159927466-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001135050.2(IGSF9):c.3419C>T(p.Ala1140Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,614,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001135050.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGSF9 | NM_001135050.2 | c.3419C>T | p.Ala1140Val | missense_variant | 21/21 | ENST00000368094.6 | NP_001128522.1 | |
IGSF9 | NM_020789.4 | c.3371C>T | p.Ala1124Val | missense_variant | 21/21 | NP_065840.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGSF9 | ENST00000368094.6 | c.3419C>T | p.Ala1140Val | missense_variant | 21/21 | 1 | NM_001135050.2 | ENSP00000357073.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250338Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135550
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461820Hom.: 0 Cov.: 37 AF XY: 0.0000468 AC XY: 34AN XY: 727218
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2024 | The c.3419C>T (p.A1140V) alteration is located in exon 21 (coding exon 20) of the IGSF9 gene. This alteration results from a C to T substitution at nucleotide position 3419, causing the alanine (A) at amino acid position 1140 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at